Clinical trials: Medically Assisted Procreation (MAP)
Medically Assisted Procreation (MAP), Oocyte Retrieval
Monocentric Randomised Controlled Trial to Assess Whether Virtual Reality Reduces the Use of Hypnotic Agents During IVF/ICSI Oocyte Retrieval
Over the last few years, audiovisual distraction devices using animation, films and 3D immersion have been developed, with the aim to provide patients with a relaxing experience that disconnects them from the operating…
- Trial name
- REVAHPOVO (NCT07190729)
- Testing
- Propofol sedation + Audiovisual distraction, Propofol sedation
- Where
- France
- Volunteers
- 52 people
- Sponsor
- Groupe Hospitalier Diaconesses Croix Saint-Simon
In Vitro Fertilization (IVF), Medically Assisted Procreation (MAP)
Microbiological Description of Sperm and Follicular Fluid Samples. Impact on IVF/ICSI Success Rates
The goal of this observational study is to quantify and identify bacteria that may be present in semen and follicular fluid samples on the day of the IVF-ICSI attempt.
- Trial name
- SPERMIBIOTE (NCT07187414)
- Where
- France
- Volunteers
- 50 people
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
Human Papillomavirus (HPV), Medically Assisted Procreation (MAP)
Prevalence of HPV Transmission During Medically Assisted Procreation Procedures
Human PapillomaVirus (HPV) are ones of the main causal agents of sexually transmitted diseases. Numerous HPV genotypes such as 16, 18, 31 or 45 are considered to be at high risk of oncogenicity especially for the anal and…
- Conditions
- Human Papillomavirus (HPV), Medically Assisted Procreation (MAP), Infertility
- Trial name
- AMPAMAVIR (NCT02524223)
- Testing
- Systematic HPV DNA assay in semen and cervicovaginal scrape, Systematic HPV DNA cervicovaginal scrape, systematic HPV Status in newborns in case of pregnancy
- Where
- 5 sites in France
- Volunteers
- 915 people
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
Infertility
Improved Medically Assisted Procreation Monitoring
Patient care in Medically Assisted Procreation (MAP) requires a close and regular monitoring of the evolution of the estradiol rate.
- Trial name
- NGAMP (NCT03274765)
- Testing
- Dosage of oestradiol
- Where
- France
- Volunteers
- 30 people
- Sponsor
- Rennes University Hospital